Could a stem cell drug restore fertility in women with scarred uteri?
NCT ID NCT05343572
First seen Nov 12, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This early-stage study tests a drug called Plerixafor to see if it can mobilize a woman's own bone marrow stem cells to repair the uterine lining. It includes 90 women aged 18-40 with Asherman's syndrome, thin uterine lining, or repeated IVF failure. The goal is to thicken the lining and improve pregnancy chances, comparing results to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASHERMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale Fertility Center
RECRUITINGOrange, Connecticut, 06477, United States
Conditions
Explore the condition pages connected to this study.